Simultaneous Determination of Losartan and Its Metabolite EXP3174 by HPLC-MS and Its Application

Li Ding
2009-01-01
Abstract:Objective:To establish an HPLC-MS method for the simultaneous determination of losartan and its metabolite EXP3174 in human plasma and their pharmacokinetics in Chinese healthy male volunteers.Methods: Plasma samples were deproteinized and separated by HPLC on a reversed phase C18 column with a mobile phase of methanol-20 mmol·L-1 ammonium acetate water solution(containing 0.1% formic acid)(60∶40,V/V).HPLC-MS was performed in the selected ion monitoring(SIM) mode using target ions at m/z 207.1 for both losartan and EXP3174.The fragment voltage was 250 V.A single oral dose of 100 mg losartan potassium tablet was administered to 12 healthy Chinese male volunteers,then the plasma concentrations of losartan and EXP3174 were detected by HPLC-MS and their pharmacokinetic parameters were evaluated.Results: Calibration curves for both losartan and EXP3174 were linear over the range of 1~2 000 ng·mL-1.The RSD of intra-run and inter-run were both less than 10%.For losartan,the pharmacokinetic parameter tmax,Cmax and t1/2 were(1.6±1.1) h,(890.2±476.4) ng·mL-1 and(2.7±1.6) h,respectively.For EXP3174,the pharmacokinetic parameter tmax,Cmax and t1/2 were(2.9±1.0) h,(1 233±611.6) ng·mL-1 and(6.4±1.2) h,respectively.Conclusion: In this experiment,the same fragment ion m/z 207.1 was selected as the target ion for both losartan and EXP3174,which improved the sensitivity and accuracy of the assay for the two analytes.The assay was proved to be sensitive,accurate and convenient.It can be applied to the pharmacokinetics study of losartan and EXP3174 in humans.
What problem does this paper attempt to address?